HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI) announced today that due to the U.S. Food and Drug Administration’s (FDA) request for additional ...

-- Commercial employee (non-executive) who was hired specifically for the launch of ROLVEDON™ (eflapegrastim-xnst) injection is the recipient of this grant -- The RSUs will vest over three years on ...

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Brittany ...

HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the presentation of ...

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

It seems people like Spectrum Pharmaceuti-cals Inc.’s new personality. Spectrum, which made a name selling generic drugs, has reinvented itself as a branded drug maker and seen sales soar. The ...

Spectrum Pharmaceuticals Inc. may have hit a snag this past summer with its brand-name cancer drug, but the company’s past three years have seen its revenue fire up. The Irvine drug developer is No. 5 ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The news pushed SPPI stock 32.7% higher to 92 cents per ...

(RTTNews) - Spectrum Pharmaceuticals (SPPI) announced an equity investment by Hanmi Pharmaceutical along with revisions to the licensing agreements for ROLONTIS and poziotinib. Hanmi entered into a ...

Boyd launched his New York-based fund in July 2012 and was named one of the best new hedge funds in 2013 at Americas Awards owing to its 48% returns in its first year. The long/short equity fund ...